🔗 Share this article

Treasury head Reeves has revealed she is planning "focused steps to tackle cost of living pressures" in the forthcoming financial statement.

During an interview with media outlets, she emphasized that reducing price rises is a collective duty of both the government and the central bank.

The UK's inflation rate is forecast to be the most elevated among the G7 industrialized countries this calendar year and the following year.

Potential Energy Bill Measures

It is understood the administration could take action to reduce utility costs, such as by cutting the current 5% level of VAT charged on energy.

A further approach is to reduce some of the regulatory levies currently added to bills.

Budgetary Limitations and Expert Expectations

The administration will obtain the next assessment from the independent fiscal watchdog, the OBR, on Monday, which will show how much scope there is for these measures.

The expectation from most experts is that Reeves will have to declare tax rises or expenditure reductions in order to adhere to her declared debt limits.

Earlier on the same day, analysis indicated there was a twenty-two billion pound gap for the Treasury chief to address, which is at the more modest range of projections.

"There's a collective task between the central bank and the administration to bear down further on some of the sources of inflation," the Chancellor informed the BBC in Washington, at the conferences of the International Monetary Fund and global financial institution.

Tax Commitments and International Issues

While a great deal of the focus has been on likely tax rises, the chancellor said the latest information from the fiscal watchdog had not changed her pledge to campaign commitments not to raise rates on income tax, VAT or social security contributions.

She blamed an "unpredictable global environment" with growing geopolitical and commercial tensions for the Budget tax moves, probably to be targeted on those "wealthiest."

Global Economic Disputes

Addressing worries about the UK's trade ties with the Asian nation she said: "Our national security always are paramount."

Last week's declaration by Chinese authorities to increase trade restrictions on critical minerals and other materials that are key for advanced tech manufacturing led American leader Donald Trump to suggest an extra 100% tariff on imports from China, increasing the prospect of an full-scale commercial conflict between the two largest economies.

The American finance chief described China's move "commercial pressure" and "a international production control attempt."

Inquired about accepting the US offer to join its battle with China, the Chancellor said she was "extremely troubled" by China's measures and urged the Beijing authorities "not to put up barriers and restrict access."

She said the action was "damaging for the global economy and generates additional headwinds."

"In my view there are fields where we need to challenge Chinese policies, but there are also valuable chances to sell into Chinese markets, including banking sector and other sectors of the economy. We've got to maintain that equilibrium correct."

The Treasury chief also confirmed she was collaborating with other major economies "on our own critical minerals strategy, so that we are reduced dependence."

Health Service Medicine Pricing and Funding

Reeves also admitted that the price the National Health Service pays for medicines could increase as a result of current talks with the US government and its drugs companies, in return for lower tariffs and investment.

A number of the world's largest drug companies have said lately that they are either pausing or scrapping operations in the United Kingdom, with several attributing the modest returns they are receiving.

Recently, the Science Minister said the price the health service pays for medicines would have to rise to halt firms and drug research funding leaving the United Kingdom.

The Chancellor informed the BBC: "We have seen because of the cost structure, that clinical trials, recent pharmaceuticals have not been offered in the United Kingdom in the manner that they are in other EU nations."

"The objective is to make sure that individuals receiving care from the National Health Service are able to receive the finest essential treatments in the globe. And so we are looking at this situation, and... seeking to attract more investment into Britain."